"MY nephew was one of these 33 patients, and so this particular point of PYRR's was particularly important to me. You can imagine why I might be upset when it is brought to my attention that the company may have went ahead with a fruitless study, and of course, I was going to look into it. I couldn't believe it. It is lost on so many that he and I did not agree on this 33 patient point. Yet, he's not insulting me, but instead asking me to PROVE it. And prove it I shall."
Great, so why don't you settle your little personal disagreement with Pyrr on the 33 via PM. As to your other point that you continue to rehash, have some of NWBO's comments been a little misleading? Maybe, depends on how you want to look at them. Won't matter if either L or Direct are successful. So again, a complete waste of time.
What's your point on the Direct data? Do you think if Direct proves to add considerable time for these patients (OS) with a high quality of life it won't be successful? Do you think if the treatment works very well for some (reduction in tumor burden providing other options like surgery, etc.), stabilizes/stops progression for some, slows the progression for others, it won't be huge (and highly profitable) success? Do you understand the potential market size? How many of these patients are cured by SOC? The bar is low. I don't have dreams of a cure, I have dreams of a viable treatment option that makes it to market. Is it possible another drug/treatment better than Direct will be discovered? Yes, that is an inherent risk in these investments. Even if it isn't Direct, I sure hope a cure is discovered in our lifetime, don't you?
What do you think will happen if they do form a collaborative trial with a CI and find success? You don't know the likelihood of this occurring or what may already be going on behind the scenes.
Of course this investment is a huge risk. It also offers a huge potential reward. As you learn more about investing you will notice a direct correlation usually exists. Either or both trials could fail. Investors may lose most if not everything, OR, NWBO could make a bunch of us Very Very wealthy. It's called BIOTECH, invest accordingly. Don't risk more than you can easily live without.
